news-med.jpg

Evotec and Novo Nordisk form strategic research alliance in diabetes and obesity

The alliance builds upon Evotec's leading drug discovery and development capabilities in diabetes and related co-morbidities Novo Nordisk accesses Evotec's integrated discovery and development platform to progress new molecules from concept to IND including Evotec's INDiGO platform

Topics: Corporate, Evotec, Novo Nordisk, diabetes, Obesity, Drug Discovery, Drug Development Read More

Most Read

Posts by Topic